Covalon Technologies (CVE:COV) Reaches New 1-Year Low - What's Next?

Key Points

• Covalon Technologies' share price fell to a new 52-week low of C$2.01, down from a close of C$2.09, with a trading volume of 32,700 shares.
• The company has a market capitalization of C$55.11 million, a P/E ratio of 22.33, and a debt-to-equity ratio of 3.28.
• Covalon Technologies specializes in developing and marketing medical products related to infection management and advanced wound care across several international markets.

Covalon Technologies Ltd. (CVE:COV - )'s share price hit a new 52-week low during mid-day trading on Friday . The stock traded as low as C$2.01 and last traded at C$2.01, with a volume of 32700 shares. The stock had previously closed at C$2.09.

Covalon Technologies Stock Performance

The company has a market capitalization of C$55.11 million, a P/E ratio of 22.33 and a beta of 0.44. The company has a quick ratio of 6.45, a current ratio of 7.27 and a debt-to-equity ratio of 3.28. The stock has a fifty day simple moving average of C$2.31 and a 200-day simple moving average of C$2.40.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.